Suppr超能文献

垂体偶发瘤

Pituitary incidentalomas.

作者信息

Molitch M E

机构信息

Center for Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA.

出版信息

Endocrinol Metab Clin North Am. 1997 Dec;26(4):725-40. doi: 10.1016/s0889-8529(05)70279-6.

Abstract

Incidental pituitary masses are commonly found during CT and MR imaging performed for a variety of reasons. Screening for hormone oversecretion by these tumors seems to be warranted. Patients with lesions greater than 1 cm should be screened for hypopituitarism. In the absence of visual field abnormalities or hypothalamic/stalk compression, it may be appropriate to observe such patients carefully with repeated MR imaging scans. A limited amount of data suggest that significant tumor enlargement occurs in less than 5% of patients with lesions smaller than 1 cm in diameter. However, all macroadenomas must start out as microadenomas, and thus periodic follow-up is indicated to assess for this possibility. Lesions larger than 1 cm in diameter by their very existence at the time of detection have already indicated a propensity for growth. Significant tumor growth occurs in just over one-quarter of such patients. Hemorrhage into such tumors is uncommon, but anticoagulation may predispose to this complication. When there is no evidence of visual field deficits, an attempt at medical therapy with a dopamine agonist or octreotide is reasonable, realizing that only 10% of such patients will respond with a decrease in tumor size. Alternatively, careful periodic observation without intervention may determine that the lesion is not growing. Surgery is indicated with evidence of tumor enlargement, especially when such growth is accompanied by compression of the optic chiasm, cavernous sinus invasion, or the development of pituitary hormone deficiencies.

摘要

偶然发现的垂体肿块常见于因各种原因进行的CT和MR成像检查中。对这些肿瘤进行激素分泌过多的筛查似乎是有必要的。对于病变大于1cm的患者,应筛查是否存在垂体功能减退。在没有视野异常或下丘脑/垂体柄受压的情况下,对这类患者进行反复的MR成像扫描仔细观察可能是合适的。有限的数据表明,直径小于1cm的病变患者中,不到5%会出现明显的肿瘤增大。然而,所有的大腺瘤最初都必定是微腺瘤,因此需要定期随访以评估这种可能性。直径大于1cm的病变在被发现时的存在本身就已表明有生长倾向。超过四分之一的此类患者会出现明显的肿瘤生长。此类肿瘤出血并不常见,但抗凝治疗可能会引发这种并发症。当没有视野缺损的证据时,尝试使用多巴胺激动剂或奥曲肽进行药物治疗是合理的,但要意识到只有10%的此类患者会出现肿瘤缩小的反应。或者,在不进行干预的情况下仔细定期观察,可能会确定病变没有生长。当有肿瘤增大的证据时,尤其是这种生长伴有视交叉受压、海绵窦侵犯或垂体激素缺乏的发生时,应考虑手术治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验